Coexistence of BCR/ABL1-positive chronic myeloid leukemia and JAK2 V617F-mutated myelofibrosis successfully treated with dasatinib and ruxolitinib
Blood Research
; : 77-79, 2019.
Article
in En
| WPRIM
| ID: wpr-739430
Responsible library:
WPRO
ABSTRACT
No abstract available.
Full text:
1
Index:
WPRIM
Main subject:
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
/
Primary Myelofibrosis
/
Dasatinib
Language:
En
Journal:
Blood Research
Year:
2019
Type:
Article